The CAN-RELEASE study: Canadian real-life effectiveness of eptinezumab in migraine patients

Summary

This study aims to evaluate effectiveness in adult migraine patients who have initiated eptinezumab according to the local prescribing information, as well as the treatment patterns and health care resource utilisation (HCRU) in clinical practice.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Accepts healthy participants: Yes

Inclusion criteria:

• The patient has either Episodic Migraine (with 4 or more episodes per month), or Chronic Migraine.
• The patient is at least age 18.
• The patient is initiating eptinezumab according to the local prescribing information as part of routine care but has not yet received their first infusion.
• The patient is willing to bring their own device and download and use the provided application software.

Exclusion criteria:

• The patient has been administered investigational drugs within at least 3 months of enrollment.
• A time gap ˃ 2 months exists between patient informed consent and the date of first infusion, unless the patient has reconsented.
• The patient has previously been enrolled and dosed in any study with eptinezumab.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

CHAMP (Calgary Headache Assessment & Management Program) Research Office Outpatient Neurology, 5th Floor Clinic 5E South Health Campus 4448 Front St SE, Calgary, AB, Canada, T3M 1M4

Principal investigator:

Farnaz Amoozegar

Clinical trial:

No

REB-ID:

REB24-0483

External links

Department of Clinical Neurosciences, CHAMP Research